Danaher (DHR) Non Operating Investment Income (2013)
Danaher (DHR) posted Non Operating Investment Income of $229.8 million for Q1 2013.
Powered by 
Analysis
Danaher (DHR) Non Operating Investment Income (2013) Analysis & Trends
Danaher has reported Non Operating Investment Income for 1 years, with the latest figure at $229.8 million in Q1 2013.
- On a quarterly basis, Non Operating Investment Income changed N/A year-over-year to $229.8 million in Q1 2013; TTM through Dec 2013 was $229.8 million, a N/A change from a year earlier, with the FY2013 full-year figure at $229.8 million, changed N/A from the prior year.
- Non Operating Investment Income was $229.8 million for Q1 2013 at Danaher.
- The five-year high for Non Operating Investment Income was $229.8 million in Q1 2013, with the low at $229.8 million in Q1 2013.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 241.68 Bn | 237.61 Bn | 8.34 Bn | - |
| 2 | Danaher | 147.34 Bn | 142.99 Bn | 3.61 Bn | - |
| 3 | Agilent Technologies | 43.34 Bn | 41.59 Bn | 1.04 Bn | - |
| 4 | Illumina | 34.58 Bn | 33.41 Bn | 770.00 Mn | - |
| 5 | Revvity | 16.31 Bn | 15.29 Bn | 416.87 Mn | - |
| 6 | Bio-Techne | 11.28 Bn | 11.01 Bn | 211.39 Mn | - |
| 7 | Bio-Rad Laboratories | 10.16 Bn | 8.54 Bn | 345.80 Mn | 458.00 Mn |
| 8 | Repligen | 9.77 Bn | 8.75 Bn | 110.04 Mn | - |
| 9 | 10x Genomics | 9.45 Bn | 8.90 Bn | 112.50 Mn | - |
| 10 | Bruker | 9.26 Bn | 9.04 Bn | 416.00 Mn | - |